Related Experiment Video

Updated: Apr 16, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1

Man Sub Kim1, Jeong-Woo Kang1, Yun Sun Park1

  • 1Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul, Republic of Korea.

Oncotarget
|March 2, 2015
PubMed

Insights

Interleukin-32θ (IL-32θ) inhibits monocytic differentiation into macrophages by reducing the expression of the key transcription factor PU.1. This finding is crucial for understanding blood cancer development and potential therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • PU.1 is a critical transcription factor for myeloid differentiation, essential for macrophage development.
  • Monocytic differentiation into macrophages plays a role in blood cancer progression.
  • Interleukin-32 (IL-32) is a recently discovered cytokine with various isoforms, including IL-32θ and IL-32β.

Purpose of the Study:

  • To investigate the function of IL-32θ in monocytic differentiation.
  • To elucidate the mechanism by which IL-32θ affects myeloid lineage commitment.
  • To explore the role of IL-32θ in THP-1 monocytic leukemia cells.

Main Methods:

  • Genetic analysis to identify sequence differences between IL-32θ and IL-32β.
  • Stable and transient expression of IL-32θ and IL-32β in THP-1 and HL-60 cells.
  • Assessment of monocytic differentiation markers (CD11b, CD18, CD36) and cell cycle factors.
  • Analysis of PU.1 and C/EBPα expression and their role in differentiation rescue.

Main Results:

  • IL-32θ expression inhibited phorbol 12-myristate 13-acetate (PMA)-induced monocytic differentiation and suppressed macrophage marker expression.
  • IL-32θ did not affect cell cycle-related factors or PMA-induced cell cycle arrest.
  • IL-32θ modulated PU.1 expression, and its re-expression rescued the differentiation defect.
  • Co-expression of PU.1 and C/EBPα synergistically rescued the differentiation defect in IL-32θ expressing cells.

Conclusions:

  • Intracellular IL-32θ inhibits monocyte differentiation into macrophages.
  • This inhibition is mediated by the attenuation of PU.1 expression.
  • IL-32θ's effect on PU.1 is a key mechanism influencing myeloid lineage commitment and potentially blood cancer development.

More Related Videos

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

9.0K
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

10.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K